Mogamulizumab-kpkc and Sinequan (Doxepin Oral Concentrate)
Determining the interaction of Mogamulizumab-kpkc and Sinequan (Doxepin Oral Concentrate) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: doxepin
Brand name: Sinequan, Sinequan, Silenor
Synonyms: Sinequan Capsules, Sinequan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc-Sinex Long-Acting
- Mogamulizumab-kpkc-Sinex Nasal Spray
- Mogamulizumab-kpkc-Singulair
- Mogamulizumab-kpkc-Singulair (Montelukast Chewable Tablets)
- Mogamulizumab-kpkc-Singulair (Montelukast Oral Granules)
- Mogamulizumab-kpkc-Singulair (Montelukast Tablets)
- Sinequan (Doxepin Oral Concentrate)-Mogamulizumab-kpkc Intravenous
- Sinequan (Doxepin Oral Concentrate)-Molindone
- Sinequan (Doxepin Oral Concentrate)-Mometasone (Oral Inhalation)
- Sinequan (Doxepin Oral Concentrate)-Mometasone and Formoterol
- Sinequan (Doxepin Oral Concentrate)-Mometasone and formoterol Inhalation
- Sinequan (Doxepin Oral Concentrate)-Mometasone Cream